Evidence map›Paper›PMID 42243162›Full record

ArticleScientific reports2026

MAGC-DTI: modality-shared space and adaptive gated interactive cross-attention for drug-target interaction prediction.

Bowen Wang, Xiaolan Xie, Haitao Zou, Shaoliang Peng

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bowen Wang *College of Computer Science and Engineering, Guilin University of Technology, Guilin, 541006, Guangxi, China.
Xiaolan XieCollege of Computer Science and Engineering, Guilin University of Technology, Guilin, 541006, Guangxi, China. xie_xiao_lan@foxmail.com.
Haitao Zou *College of Computer Science and Electronic Engineering, Hunan University, Changsha, 410082, Hunan, China.
Shaoliang PengCollege of Computer Science and Electronic Engineering, Hunan University, Changsha, 410082, Hunan, China. slpeng@hnu.edu.cn.

Funding

Hunan Science and Technology Innovation Plan 2025ZYJ003Key R&D Program of Hunan Province 2023GK2004National Key Research and Development Program of China 2023YFC3503400National Natural Science Foundation of China 62262011The Guangxi Key Technologies R&D Program GuikeAB23026036The Innovative Research Group Project of Hunan Province 2024JJ1002The NSFC-FDCT Grants 62361166662
6 · The paper itself

Abstract

Accurate drug-target interaction (DTI) prediction is crucial for drug repurposing and accelerating drug development. Although deep learning has advanced DTI prediction, existing methods struggle with two key challenges: (i) capturing complex hierarchical patterns in protein sequences, and (ii) enabling effective bidirectional information exchange between drug and protein modalities. We propose MAGC-DTI, an end-to-end cross-modal framework that integrates bidirectional information exchange into both feature extraction and fusion stages through three key innovations: (i) multi-scale attention aggregation (MSAA) for hierarchical protein pattern capture, (ii) adaptive gated interactive cross attention (AGICA) for context-aware cross-modal interaction, and (iii) multi-path residual classifier (MPRC) for modality-preserving fusion. Comprehensive evaluations on six benchmark datasets show that MAGC-DTI generally achieves favorable performance relative to seven state-of-the-art baselines, with competitive results in cold-start and cross-domain scenarios. The model also provides interpretable insights through attention visualization and case studies confirm the biological relevance of learned representations.

Indexed as

Deep LearningDrug RepositioningProteinsHumansProteinsCold-start predictionCross-domain generalizationCross-modal learningDeep learningDrug-target interactionMulti-scale features

Identifiers

PMID42243162
PMCPMC13473133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.